Renal Cell Carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Neoplastic Process
|
12
|
66
|
0.500 |
None |
0.900 |
1 |
26
|
1991 |
2019 |
Adenoid Cystic Carcinoma
|
disease |
Neoplasms
|
Neoplastic Process
|
11
|
27
|
0.500 |
None |
0.933 |
1 |
3
|
1996 |
2017 |
Choroid Plexus Carcinoma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
1
|
1
|
0.500 |
None |
1.000 |
0 |
1
|
2001 |
2019 |
Malignant tumor of colon
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
15
|
37
|
0.500 |
None |
0.966 |
0 |
1
|
1991 |
2020 |
Carcinoma of lung
|
disease |
Neoplasms; Respiratory Tract Diseases
|
Neoplastic Process
|
11
|
28
|
0.500 |
None |
0.942 |
0 |
1
|
1989 |
2020 |
Cervix carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
2
|
7
|
0.500 |
None |
0.879 |
0 |
1
|
1991 |
2019 |
Stomach Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
13
|
47
|
0.500 |
None |
1.000 |
0 |
1
|
1991 |
2018 |
Uterine Cervical Neoplasm
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
16
|
69
|
0.470 |
None |
1.000 |
1 |
8
|
1999 |
2016 |
Breast adenocarcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
3
|
5
|
0.460 |
None |
1.000 |
0 |
1
|
1995 |
2017 |
Nasopharyngeal Neoplasms
|
group |
Neoplasms; Stomatognathic Diseases; Otorhinolaryngologic Diseases
|
Neoplastic Process
|
6
|
17
|
0.410 |
None |
1.000 |
1 |
5
|
2005 |
2016 |
Glioblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
22
|
115
|
0.400 |
None |
0.976 |
1 |
48
|
1990 |
2019 |
Adenocarcinoma of lung (disorder)
|
disease |
Neoplasms
|
Neoplastic Process
|
37
|
211
|
0.400 |
None |
0.991 |
1 |
81
|
1992 |
2019 |
BONE MARROW FAILURE SYNDROME 5
|
disease |
|
Disease or Syndrome
|
1
|
2
|
0.400 |
limited |
|
0 |
2
|
|
|
Hepatoblastoma
|
disease |
Neoplasms
|
Neoplastic Process
|
3
|
5
|
0.400 |
None |
0.824 |
0 |
1
|
1991 |
2018 |
BASAL CELL CARCINOMA, SUSCEPTIBILITY TO, 7
|
disease |
|
Finding
|
1
|
7
|
0.400 |
None |
|
0 |
7
|
|
|
Lymphoma
|
group |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
6
|
10
|
0.400 |
None |
0.955 |
0 |
1
|
1986 |
2019 |
GLIOMA SUSCEPTIBILITY 1
|
phenotype |
|
Finding
|
2
|
7
|
0.400 |
None |
|
0 |
6
|
|
|
Anaplastic astrocytoma
|
disease |
Neoplasms
|
Neoplastic Process
|
1
|
2
|
0.400 |
None |
0.933 |
0 |
2
|
1991 |
2018 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
26
|
98
|
0.200 |
None |
0.947 |
5 |
6
|
1987 |
2020 |
Squamous cell carcinoma of skin
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
12
|
54
|
0.200 |
None |
0.923 |
1 |
33
|
1993 |
2019 |
Gallbladder Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
4
|
11
|
0.200 |
None |
0.892 |
1 |
6
|
1994 |
2019 |
Gastric Adenocarcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
30
|
188
|
0.200 |
None |
1.000 |
1 |
67
|
1992 |
2019 |
Esophageal carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
16
|
102
|
0.200 |
None |
0.985 |
1 |
67
|
1990 |
2020 |
Adenocarcinoma of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
16
|
96
|
0.200 |
None |
0.950 |
1 |
31
|
1992 |
2019 |
Multiple Myeloma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases; Cardiovascular Diseases
|
Neoplastic Process
|
15
|
76
|
0.200 |
None |
1.000 |
1 |
26
|
1992 |
2020 |